new oral glp 1 agonist Orforglipron, an Small-Molecule GLP-1 Receptor for Obesity Treatment Oral Semaglutide Approved to Reduce
Description
Many providers recommend extending the titration period for patients over 50, spending more weeks at each dose level before stepping up, rather than following the most aggressive standard schedule
55 In a broad sense, these findings suggest that effects of GIP on cardiac remodeling may differ based on the ambient pathophysiologic milieu
Dose adjustments should never be made independently
And in recent years, their popularity has soared due to their effectiveness and versatility.
00360-0/asset/06397771-b461-4bfd-bc69-cd0a43d464aa/main.assets/fx1.jpg)
2021;372:n71
